Market Overview:
The global organ preservation solutions market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market is segmented by type, application, and region. By type, the market is segmented into Viaspan, Custodial, siRNA Transplant Solutions, and others. By application, the market is segmented into hypothermic perfusion preservation (HPP), static cold storage (SCS), and others. The North American region dominates the global organ preservation solutions market in terms of revenue share followed by Europe and Asia Pacific regions respectively.
Product Definition:
Organ Preservation Solutions is a medical term that refers to the various methods used to keep organs alive outside of the body. The importance of Organ Preservation Solutions is vast, as it allows for doctors to transplant organs into patients who need them, saving lives in the process.
Viaspan:
Viaspan is a medical device that helps in the preservation of organs and tissues. It’s major application is in kidney preservation, however it can be used for other applications as well. Viaspan has been studied extensively and has had positive results with regards to organ transplantation procedures.
Custodial:
Custodial is a process in which the body or organs are stored temporarily during the time when there is no hope for recovery. In many countries, it is legal to store a body or organs for research purposes even if death has not occurred yet. The purpose of this procedure is to preserve them until the person dies naturally and an autopsy can be performed to study how they would have died.
Application Insights:
Hypothermic perfusion preservation (HPP) accounted for the largest revenue share in 2017 and is anticipated to maintain its dominance over the forecast period. HPP solutions help in maintaining organs at a suitable temperature during transit and storage, which helps prevent tissue damage. The other advantages of using this technology include reduced blood loss during surgery as compared to conventional methods, reduced organ trauma due to faster recovery time and cost-effectiveness among others.
The static cold storage (SCS) segment is expected register significant growth over the forecast period owing to its non-invasive procedure that does not require any type of anesthesia or sedation while offering rapid recovery times post transplantation with minimal risk of complications associated with it.
Regional Analysis:
North America dominated the global organ preservation solutions market in 2017. The presence of well-developed healthcare infrastructure, high adoption rate of advanced technologies and a large number of transplantation procedures are some factors responsible for its large share. In addition, increasing demand for organ donation is also expected to drive the regional market over the forecast period. According to data published by U.S Department of Health and Human Services (HHS), more than 116,000 people are waiting for transplants as of January 2018; this number includes about 69,000 candidates on the national list and another 35,000 on separate lists in each state.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising healthcare expenditure levels coupled with growing awareness regarding organ donation among individuals living in this region as compared to other regions’ countries or states within countries such as India or China etc.
Growth Factors:
- Increasing demand for organ transplantation procedures: The increasing demand for organ transplantation procedures is one of the key growth drivers for the global organ preservation solutions market. This is because the use of organ preservation solutions helps to improve the quality and viability of organs, which in turn increases the success rate of transplants.
- Technological advancements in organ preservation methods: The technological advancements in organ preservation methods are another key factor driving the growth of this market. This is because these advancements have led to the development of novel and more efficient methods for preserving organs, which has increased their acceptance among surgeons and patients alike.
- Rising incidence of chronic diseases: The rising incidence of chronic diseases such as diabetes and heart disease is also contributing to the growth of this market, as it leads to an increase in cases requiring transplants surgeries.
- Growing awareness about donation and transplantation: There has been a growing awareness about donation and transplantation across different regions worldwide, owing to which an increasing number people are now willing to donate their organs after death. This is providing a boost to the global market for organ preservation solutions products/services . 5) Rise in number os surgical centers offering transplants surgeries: There has been a rise in number os surgical centers offering transplants surgeries across different regions worldwide, owing to which there is an increase in demand for effective means fo rpreserving organs during transportation between these centers
Scope Of The Report
Report Attributes
Report Details
Report Title
Organ Preservation Solutions Market Research Report
By Type
Viaspan, Custodial, siRNA Transplant Solutions, Others
By Application
Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others
By Companies
Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB, ToleroTech, Inc, CryoLife, Inc., Claris Lifesciences Limited, BioTime, Inc., st Century Medicine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Organ Preservation Solutions Market Report Segments:
The global Organ Preservation Solutions market is segmented on the basis of:
Types
Viaspan, Custodial, siRNA Transplant Solutions, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dr. Franz Köhler Chemie
- Teva Pharmaceutical Industries Ltd.
- Lifeline Scientific
- Bristol-Myers Squibb
- BioLife Solutions, Inc.
- XVIVO Perfusion AB
- ToleroTech, Inc
- CryoLife, Inc.
- Claris Lifesciences Limited
- BioTime, Inc.
- st Century Medicine
Highlights of The Organ Preservation Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Viaspan
- Custodial
- siRNA Transplant Solutions
- Others
- By Application:
- Hypothermic Perfusion Preservation (HPP)
- Static Cold Storage (SCS)
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Organ Preservation Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Organ Preservation Solutions is a company that specializes in preserving organs and tissue for transplant. They provide a wide range of services, including organ procurement, storage, and transport.
Some of the key players operating in the organ preservation solutions market are Dr. Franz K¶hler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB, ToleroTech, Inc, CryoLife, Inc., Claris Lifesciences Limited, BioTime, Inc., st Century Medicine.
The organ preservation solutions market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Organ Preservation Solutions Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Organ Preservation Solutions Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Organ Preservation Solutions Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Organ Preservation Solutions Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Organ Preservation Solutions Market Size & Forecast, 2020-2028
4.5.1 Organ Preservation Solutions Market Size and Y-o-Y Growth
4.5.2 Organ Preservation Solutions Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Viaspan
5.2.2 Custodial
5.2.3 siRNA Transplant Solutions
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hypothermic Perfusion Preservation (HPP)
6.2.2 Static Cold Storage (SCS)
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Organ Preservation Solutions Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Organ Preservation Solutions Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Viaspan
9.6.2 Custodial
9.6.3 siRNA Transplant Solutions
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hypothermic Perfusion Preservation (HPP)
9.10.2 Static Cold Storage (SCS)
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Viaspan
10.6.2 Custodial
10.6.3 siRNA Transplant Solutions
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hypothermic Perfusion Preservation (HPP)
10.10.2 Static Cold Storage (SCS)
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Viaspan
11.6.2 Custodial
11.6.3 siRNA Transplant Solutions
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hypothermic Perfusion Preservation (HPP)
11.10.2 Static Cold Storage (SCS)
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Viaspan
12.6.2 Custodial
12.6.3 siRNA Transplant Solutions
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hypothermic Perfusion Preservation (HPP)
12.10.2 Static Cold Storage (SCS)
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Viaspan
13.6.2 Custodial
13.6.3 siRNA Transplant Solutions
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hypothermic Perfusion Preservation (HPP)
13.10.2 Static Cold Storage (SCS)
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Organ Preservation Solutions Market: Competitive Dashboard
14.2 Global Organ Preservation Solutions Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dr. Franz Köhler Chemie
14.3.2 Teva Pharmaceutical Industries Ltd.
14.3.3 Lifeline Scientific
14.3.4 Bristol-Myers Squibb
14.3.5 BioLife Solutions, Inc.
14.3.6 XVIVO Perfusion AB
14.3.7 ToleroTech, Inc
14.3.8 CryoLife, Inc.
14.3.9 Claris Lifesciences Limited
14.3.10 BioTime, Inc.
14.3.11 st Century Medicine
